KAITLYN SMITH: Open Payments
NPI 1245798032 · CONYERS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,806 in 136 payments from 21 companies in 2025. Trend: 2023 $1,557 · 2024 $2,083 · 2025 $2,806
Food & beverage: $2,806
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 31 | $545 |
| Galderma Laboratories, L.P. | 16 | $362 |
| GENZYME CORPORATION | 9 | $333 |
| UCB, Inc. | 18 | $290 |
| Regeneron Healthcare Solutions, Inc. | 10 | $242 |
| Novartis Pharmaceuticals Corporation | 7 | $192 |
| LEO Pharma Inc. | 8 | $172 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 9 | $149 |
| MAYNE PHARMA COMMERCIAL LLC | 4 | $91 |
| Organon LLC | 7 | $88 |
Products named: DUPIXENT, NEMLUVIO, Bimzelx, SKYRIZI, RINVOQ, ADBRY, Rhapsido, BOTOX.
Industry payments across GA — which companies pay providers there.
